The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease.

@article{Wiig2010TheSO,
  title={The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease.},
  author={Elisabeth Hemmersam Wiig and Peter Annas and Hans Basun and Niels Andreasen and Lars Lannfelt and Henrik Zetterberg and Kaj Blennow and Lennart Minthon},
  journal={Acta neurologica Scandinavica},
  year={2010},
  volume={121 3},
  pages={
          186-93
        }
}
OBJECTIVES To explore the longitudinal stability of measures of cognition during treatment with acetylcholinesterase inhibitors (AchEI) in patients with Alzheimer's disease (AD). MATERIALS AND METHODS Cognitive status was measured in a cohort of 60 patients at 6 months after initiation of treatment with AchEI (baseline) and after an additional 6 months of treatment (endpoint). A Quick Test of Cognitive Speed (AQT), Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog), and MMSE… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 14 CITATIONS

Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer’s disease: a cohort study

VIEW 4 EXCERPTS
CITES METHODS
HIGHLY INFLUENCED

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease

VIEW 1 EXCERPT
CITES METHODS